Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging-Reference-Cited by-同舟云学术

Development and Characterization of an Antibody-Labeled Super-Paramagnetic Iron Oxide Contrast Agent Targeting Prostate Cancer Cells for Magnetic Resonance Imaging

Published:2014-05-12 Issue:5 Volume:9 Page:e97220
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bates David,Abraham Suraj,Campbell Michael,Zehbe Ingeborg,Curiel Laura

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. [Anonymous]. Canadian cancer registry (CCR). 2010.

2. Prostate-specific antigen nadir and cancer-specific mortality following hormonal therapy for prostate-specific antigen failure;AJ Stewart;J Clin Oncol,2005

3. Risk factors and quality of life for post-prostatectomy vesicourethral anastomotic stenosis;R Wang;Urology,2011

4. Other biomarkers for detecting prostate cancer;L Nogueira;BJU Int,2010

5. Induction of effective antitumor response after mucosal bacterial vector mediated DNA vaccination with endogenous prostate cancer specific antigen;S Ahmad;J Urol,2011

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody conjugates as CT/MRI Theranostics for diagnosis of cancers: a review of recent trends and advances;Sensors & Diagnostics;2024

2. Recent Advances of Iron Oxide Nanoparticles-Based Nanomedicine for Prostate Cancer (Review);Molecular Biomarkers for Cancer Diagnosis and Therapy;2024

3. Upgrading gold to green nanoparticles: applications in prostate cancer;Advances in Natural Sciences: Nanoscience and Nanotechnology;2023-05-18

4. Biomolecule-functionalized nanoformulations for prostate cancer theranostics;Journal of Advanced Research;2022-11

5. Glu-Urea-Lys Scaffold Functionalized Superparamagnetic Iron Oxide Nanoparticles Targeting PSMA for In Vivo Molecular MRI of Prostate Cancer;Pharmaceutics;2022-09-26